![Edward Brennan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Edward Brennan
President chez InClinica, Inc.
Fortune : 182 125 $ au 31/05/2024
Profil
Edward J.
Brennan is currently the Director at Skinject, Inc., the President & Chief Medical Officer at InClinica, Inc., and the Chief Medical Officer at Medicus Pharma Ltd.
Previously, he served as an Independent Director at Solarvest BioEnergy, Inc. in 2020.
He also held positions as a Medical Director at Wyeth-Ayerst Research and GlaxoSmithKline LLC.
Additionally, he served as the President-BioSciences Division at FSD Pharma, Inc. Dr. Brennan obtained a doctorate degree from Temple University School of Medicine and an undergraduate degree from Philadelphia College of Pharmacy.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
0,77% | 24/10/2023 | 125 000 ( 0,77% ) | 182 125 $ | 31/05/2024 |
Postes actifs de Edward Brennan
Sociétés | Poste | Début |
---|---|---|
InClinica, Inc.
![]() InClinica, Inc. BiotechnologyHealth Technology InClinica, Inc. provides clinical trial services to western biotechnology, pharmaceutical and medical device companies. It also offers clinical trial management, pharmacovigilance and monitoring services. The company was founded in 2016 and is headquartered in Wayne, PA. | President | - |
Skinject, Inc.
![]() Skinject, Inc. Hospital/Nursing ManagementHealth Services Skinject, Inc. operates as a biotechnology company. It offers treatment for common forms of non melanoma skin cancer, basal cell, and squamous cell carcinoma. The company was founded by Louis D. Falo and is headquartered in Pittsburgh, PA. | Directeur/Membre du Conseil | 18/10/2023 |
Anciens postes connus de Edward Brennan
Sociétés | Poste | Fin |
---|---|---|
SOLARVEST BIOENERGY INC. | Directeur/Membre du Conseil | 25/11/2020 |
GlaxoSmithKline LLC
![]() GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Directeur Technique/Scientifique/R&D | - |
Wyeth-Ayerst Research | Directeur Technique/Scientifique/R&D | - |
FSD PHARMA INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Edward Brennan
Temple University School of Medicine | Doctorate Degree |
Philadelphia College of Pharmacy | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
SOLARVEST BIOENERGY INC. | Utilities |
FSD PHARMA INC. | Health Technology |
Entreprise privées | 4 |
---|---|
InClinica, Inc.
![]() InClinica, Inc. BiotechnologyHealth Technology InClinica, Inc. provides clinical trial services to western biotechnology, pharmaceutical and medical device companies. It also offers clinical trial management, pharmacovigilance and monitoring services. The company was founded in 2016 and is headquartered in Wayne, PA. | Health Technology |
Wyeth-Ayerst Research | |
GlaxoSmithKline LLC
![]() GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Skinject, Inc.
![]() Skinject, Inc. Hospital/Nursing ManagementHealth Services Skinject, Inc. operates as a biotechnology company. It offers treatment for common forms of non melanoma skin cancer, basal cell, and squamous cell carcinoma. The company was founded by Louis D. Falo and is headquartered in Pittsburgh, PA. | Health Services |